Assessment of visual outcomes of a new trifocal intraocular lens for distance, intermediate and near visual acuity
- Conditions
- Health Condition 1: H259- Unspecified age-related cataract
- Registration Number
- CTRI/2022/01/039218
- Lead Sponsor
- BIOTECH EUROPE MEDITECH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patient with bilateral age related senile cataract
2. grade of cataract permitting optical biometry
3. no ocular/systemic contraindication for surgery
4. a patient with preoperative corneal astigmatism less than 1D in each eye
5. normal macular functions with normal anantomy of macula as seen on optical coherence tomography
6. no history or evidence of ocular anatomical or functional disorders other than cataract including strabismus neuro-ophthalmological disorders of optic nerve or high visual functions corneal pathologies disorders of uvea vitreous pathologies retinal disorders
7. no systemic contraindications to surgery under local anaesthesia
8. patient willing to undergo the investigations and comply with the follow-up schedule
1. cataract precluding optical biometry
2. posterier-segment pathology
3. media opacity other than cataract
4. corneal higher order aberrations more than 0.3 micron as measured on ray-tracing wavefront aberrometer
5. patients with potential for intraoperative complications such as floppy iris syndrome and pseudo-exfoliation syndrome
6. cases where intra-operative complications compromise IOL placement with proper centration in the capsule bag
7. patient unwilling to undergo the required investigations or follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. visual acuity <br/ ><br>uncorrected and best corrected distance intermediate and near visual acuity <br/ ><br>2. quality of visionTimepoint: 1. Pre-operative visit <br/ ><br>2. Operative visit <br/ ><br>3. Post-operative visit 1 - Day 1 <br/ ><br>4. Post-operative visit 2 - 1 month <br/ ><br>3. Post-operative visit 3 - 3 months <br/ ><br>3. Post-operative visit 4 - 6 months <br/ ><br>3. Post-operative visit 5 - 12 months
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI